| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-14 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-12 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |